Patents by Inventor Scott Rudge

Scott Rudge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LSD DERIVATIVES, SYNTHESIS & METHOD FOR TREATMENT OF DISEASES AND DISORDERS
    Publication number: 20230357243
    Abstract: LSD derivative compounds and polymorphs thereof, methods for their synthesis, compositions and treatment of diseases and disorders are described herein, the compounds having the structure of Formula I: including pharmaceutically acceptable salts, hydrates, solvates, tautomers, enantiomers, diastereomers, racemates, polymorphs or combinations thereof; wherein: R1 to R14 are each independently selected from H, or a substituted or unsubstituted hydrocarbon group and X is selected from a halo group.
    Type: Application
    Filed: June 26, 2023
    Publication date: November 9, 2023
    Inventors: Hooshmand Sheshbaradaran, Scott Rudge, Abdi Ghaffari, Stefan Soderman, Peter Duspara
  • LSD DERIVATIVES, SYNTHESIS & METHOD FOR TREATMENT OF DISEASES AND DISORDERS
    Publication number: 20230219955
    Abstract: LSD derivative compounds and polymorphs thereof, methods for their synthesis, compositions and treatment of diseases and disorders are described herein, the compounds having the structure of Formula I: including pharmaceutically acceptable salts, hydrates, solvates, tautomers, enantiomers, diastereomers, racemates, polymorphs or combinations thereof; wherein: R1 to R14 are each independently selected from H, or a substituted or unsubstituted hydrocarbon group and X is selected from a halo group.
    Type: Application
    Filed: September 20, 2022
    Publication date: July 13, 2023
    Inventors: Hooshmand Sheshbaradaran, Scott Rudge, Abdi Ghaffari, Stefan Soderman, Petar Duspara
  • Methods and systems for event based notifications
    Patent number: 10891260
    Abstract: Methods and systems are disclosed for analyzing equipment data, determining an occurrence of an event, and transmitting a message based on the event.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: January 12, 2021
    Assignee: RMC PHARMACEUTICAL SOLUTIONS, INC.
    Inventors: Scott Rudge, Korben Knudson
  • METHODS AND SYSTEMS FOR EVENT BASED NOTIFICATIONS
    Publication number: 20190286616
    Abstract: Methods and systems are disclosed for analyzing equipment data, determining an occurrence of an event, and transmitting a message based on the event.
    Type: Application
    Filed: May 31, 2019
    Publication date: September 19, 2019
    Inventors: Scott Rudge, Korben Knudson
  • Methods and systems for event based notifications
    Patent number: 10353868
    Abstract: Methods and systems are disclosed for analyzing equipment data, determining an occurrence of an event, and transmitting a message based on the event.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: July 16, 2019
    Assignee: RMC PHARMACEUTICAL SOLUTIONS, INC.
    Inventors: Scott Rudge, Korben Knudson
  • METHODS AND SYSTEMS FOR EVENT BASED NOTIFICATIONS
    Publication number: 20180276235
    Abstract: Methods and systems are disclosed for analyzing equipment data, determining an occurrence of an event, and transmitting a message based on the event.
    Type: Application
    Filed: May 30, 2018
    Publication date: September 27, 2018
    Inventors: Scott Rudge, Korben Knudson
  • SMS NOTIFICATION SOFTWARE
    Publication number: 20180146347
    Abstract: Software that is able to detect a signal being passed from equipment to a computer, capture that signal and turn it into a message that is transmitted to an end user.
    Type: Application
    Filed: April 28, 2017
    Publication date: May 24, 2018
    Inventors: Scott Rudge, Korben Knudson
  • Magnetically Targetable Mitomycin C Compositions and Methods of Their Use
    Publication number: 20070274907
    Abstract: The present embodiments are directed to compositions and methods of delivering the compositions that comprise mitomycin C and superior magnetically targetable carrier particles. As the compositions are magnetically targetable, their use allows the localization of mitomycin C to particular locations within a patient. This allows for an increase in the effective concentration or a decrease in systemic exposure of mitomycin C in a patient.
    Type: Application
    Filed: May 12, 2004
    Publication date: November 29, 2007
    Inventors: Yuhua Li, Caryn Peterson, Scott Rudge, Suzanne Stevens, Gilles Tapolsky